MedTrace Logo

Pain Phenotype and Response to Corticosteroid Injection in Patients With Subacromial Pain Syndrome (SAPS)

NCT07792421 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2026-08-28

No results posted yet for this study

Summary

The goal of this prospective cohort study is to investigate whether pain phenotype is associated with subsequent change in pain intensity after corticosteroid injection given as part of routine care in patients daiagnosed with SAPS.

The main question it aims to answer is:

Does change in shoulder pain from baseline to 4 weeks after corticosteroid injection differ between patients classified as having a nociplastic pain phenotype and those classified as having a non-nociplastic pain phenotype?

Conditions

  • Subacromial Pain Syndrome
  • Rotator Cuff Related Shoulder Pain
  • Shoulder Pain
  • Shoulder Impingement Syndrome
  • SAPS

Interventions

PROCEDURE

Clinical evaluation

Participants undergo a standardiced clinical assessment including medical history, specific orthopedic shoulder test, diagnostic ultrasound and x-ray of the shoulder. Participants are included in this cohort only if they receive a corticosteroid injection as part of usual clinical care. The decision to administer the corticosteroid injection, is made part of usual clinical care and is independent of participation in the study. All corticosteroid injections are administered by experience clinicians and are ultrasound guided into the subacromial bursa

Sponsors & Collaborators

  • Vejle Hospital

    lead OTHER

Principal Investigators

  • Thomas Sørensen, PT, Cand.san · University of Southern Denmark

  • kim G Ingwersen, PT, PhD · University of Southern Denmark

  • Claus Varnum, Prof., PhD, MD · University of Southern Denmark

  • Henrik B Vægter, Prof., PT, PhD · Odense University Hospital and University of Southern Denmark

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-15
Primary Completion
2028-09-30
Completion
2028-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07792421 on ClinicalTrials.gov